PNC Financial Services Group
OVID icon

PNC Financial Services Group’s Ovid Therapeutics OVID Stock Holding History

PNC Financial Services Group’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Hold
903
– – ﹤0.01% 4578
2025
Q4 		$1.47K Hold
903
– – ﹤0.01% 4600
2025
Q3 		$1.17K Hold
903
– – ﹤0.01% 4641
2025
Q2 		$298 Buy
903
+897
+14,950% +$270 ﹤0.01% 4758
2025
Q1 		$2 Sell
6
-255
-98% -$157 ﹤0.01% 4880
2024
Q4 		$244 Buy
+261
New +$292 ﹤0.01% 4629
2024
Q1 		– Sell
-10
Closed -$32 – 4782
2023
Q4 		$32 Buy
+10
New +$34 ﹤0.01% 4587
2022
Q4 		– Sell
-2,000
Closed -$4K – 4833
2022
Q3 		$4K Hold
2,000
– – ﹤0.01% 4027
2022
Q2 		$4K Buy
+2,000
New +$4.83K ﹤0.01% 4057

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PNC Financial Services Group's OVID Position: Q1 2026 in Review

PNC Financial Services Group held its Ovid Therapeutics (OVID) position steady in Q1 2026 at 903 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #4578.

PNC Financial Services Group first reported a position in OVID in Q2 2022 and has held it in 9 quarters since. The position peaked at $4K in Q3 2022. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • PNC Financial Services Group held 903 shares of Ovid Therapeutics worth $2K as of Q1 2026.
  • PNC Financial Services Group left its Ovid Therapeutics share count unchanged in Q1 2026.
  • Ovid Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4578 holding.
  • PNC Financial Services Group first reported a position in Ovid Therapeutics in Q2 2022 and has held it in 9 quarters since.
  • PNC Financial Services Group's Ovid Therapeutics position peaked at $4K in Q3 2022.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.